The current study involved synthesizing Schiff base ligand, 2-(2,5-dimethoxybenzylidene)hydrazine-1-carbothioamide (L) by combining thiosemicarbazide (Th) with 2,5-dimethoxybenzaldehyde (2,5-Dmb), and synthesizing its novel complexes of Co(II), Ni(II), and Cu(II) ions. Elemental analysis, conductance measurements, magnetic susceptibility, molecular weight estimations, FT-IR, ESI-Mass, and UV-Vis spectrum analysis have confirmed the ligand and its metal complexes. The experiment data demonstrated that the ligand binds to the metal atom in a bidentate manner through the N and S atoms. The cytotoxic activity of the synthesized complexes was tested against brine shrimp. All the complexes showed cytotoxic activity; among them, ligands showed a better result with LC₅₀ value of 36.93 µg/mL than complexes. Using disc diffusion, the antibacterial action was tested against two Gram-positive bacteria and two Gram-negative bacteria. [Ni(L)₂] was more effective against E. coli than the other compounds. The results verified the formation of the novel complexes, and the Ni-complex has the potential to generate novel antibacterial compounds for use in biomedical applications.
No takes yet. Share an insight, caveat, or question.
Sultana et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: